Seth Concors (he/him)
@SethConcorsMD
Followers
688
Following
3K
Media
67
Statuses
475
Assistant Professor Surgical Oncology @WinshipAtEmory specializing in GI / HPB Malignancies | previously @MDAndersonNews, @PennSurgery, and @nyugrossman
Atlanta, GA
Joined December 2017
Register today for the October 27 #CSSP webinar, “Technical Standards for Neuroendocrine Cancer Surgery.” Surgeons who attend the webinar are eligible to receive Continuing Medical Education credits. https://t.co/HK2Wsddjma
1
3
13
My friend and colleague @SethConcorsMD takes on a very challenging topic of primary tumor resection in the face of metastatic disease in NETs. @NANETS1 @WinshipAtEmory @EmorySurgery
0
1
16
Here @UABSurgery for @NANETS1 regional meeting. Excited to hear from thought leaders in the field!
1
1
15
No better way to be welcomed on my first day at NET clinic @WinshipAtEmory than my colleague and surgeon extraordinaire @SethConcorsMD coming up with this cute cartoon of our very rapidly growing NET team here at Emory, lead by the one and only #DanHalperin 😊 🦓 👨⚕️ 🚀
6
3
79
Last chance to register! Explore management of sarcomatosis & metastatic GIST, including the role of cytoreduction +/- HIPEC. Learn about patient selection, timing & outcomes. See you there: https://t.co/EZvLuablbf
0
2
7
Wondering about what to do for NEN patients with peritoneal metastases...? Worry not, check this paper... The Peritoneal Surface Malignancies Consortium Group just dropped a bunch of papers on various cancers @AGangiMD @PamelaKunzMD @SethConcorsMD
https://t.co/P9Ik5lysZH
acsjournals.onlinelibrary.wiley.com
Peritoneal metastases (PM) can develop in up to 60% of patients with gastroenteropancreatic neuroendocrine neoplasms (NENs), which predominantly originate from primary midgut tumors. This update to...
1
7
28
January Issue: Effect of Minimally Invasive #Gastrectomy on Return to Intended Oncologic Therapy for #GastricCancer @MihirMShah1 @caitlin_sok @SethConcorsMD @skmaithel
https://t.co/B5JLGjpeOX
@DavidCabaMD
@SyedAAhmad5
0
8
21
📅 Join the PSM DSWG for an engaging case-based discussion on management strategies for patients with gastric cancer and peritoneal metastases. Register now: https://t.co/I7WRdZ2kvY
0
2
10
Why I am like I am.
0
0
5
Labor of HDAC love.
Differential Effects of HDAC6 Inhibition Versus Knockout... : Transplantation https://t.co/7eAu7tAmg1 This was a long time coming - more of the story ahead. Thanks to SEVEN Penn residents who drove this from idea to fruition. @pennsurgery @Penn_Transplant @chop1855
0
0
9
Exceptionally well presented by @caitlin_sok — Minimally Invasive Gastrectomy Impacts RIOT @EmorySurgery @EmoryMedicine @WinshipAtEmory @SocSurgOnc @emoryhealthcare #SSO2024
0
4
17
We welcome Sandra L. Wong, MD, MS as our new dean today! She is an accomplished surgical oncologist and researcher, and will also serve as the chief academic officer for Emory Healthcare. #Welcome, Dean Wong! ➡️ https://t.co/ll9Us3JdVz
#Emory #EmoryHealthcare
news.emory.edu
Sandra L. Wong, an accomplished surgical oncologist and researcher, will begin her tenure as dean of Emory University School of Medicine and chief academic officer for Emory Healthcare in March 2024.
0
11
64
Powerful address by President @KellyKhunt #SSO2024 📢 Empowering surgeons 💪🏻 goes through ✨Leadership ✨Mentorship: be a multiplier, not a diminisher ✨Collaboration: bring together pioneers, integrators, drivers & guardians @mdandersonnews @sandralwong @drcnclarke @tarikingmd
2
21
71
We need a bigger room! A testament to the interest and excitement in PSM management at #SSO2024
Standing room only for #SSO2024 great debates #PSM #HIPEC - prophylactic CRS/HIPEC in high risk T4 colorectal cancer? #Lambert vs @KVotanopoulos with @FabianJohnston keeping the peace 🥊@SocSurgOnc
0
0
2
So fun to see everyone at #SSO2024
What a terrific day at #SSO2024! It was great to present and see colleagues and friends at @MDAndersonNews' booth. Congrats to SSO president @KellyKHunt on a superb conference, which is fueling connections and advancing surgical innovation for the benefit of patients. #EndCancer
1
0
5
💛🎗️On this special 02/29, we recognize #RareDiseaseDay, shedding light on all rare diseases, including appendix cancer, and its extraordinary community. Together, let's raise awareness and educate ourselves to spread accurate info about #appendixcancer. https://t.co/xD3pff35fK
1
4
10
Don't miss module 3 of our PSM series! A case-based format & data review will facilitate an understanding of short-term complications associated with CRS/HIPEC. Expert speakers will guide you in recognizing & effectively managing these complications. 📝: https://t.co/18TXqWWFFD
0
5
12
Thanks to @SocSurgOnc for a phenomenal #ACT2024 meeting
1
4
18
Great first day at the @SocSurgOnc Advanced Cancer Therapies (SSO ACT) Conference! We’re proud to be a sponsor yet again this year. Stay tuned for more photos including this year’s grant recipients! #ACT2024
0
2
17